Old Web
English
Sign In
Acemap
>
authorDetail
>
J Toretsky
J Toretsky
Biology
Geldanamycin
Protein structure
Wild type
Mutant
4
Papers
469
Citations
0.07
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
1620O Phase I study of TK216, a novel anti-ETS agent for Ewing sarcoma
2020
Annals of Oncology
Joseph A. Ludwig
Noah Federman
Pete Anderson
M. E. Macy
L.E. Davis
R.F. Riedel
J.A. Muscal
N. C. Daw
Ravin Ratan
J Toretsky
X. Ianopulos
F. J. Hsu
J. B. Breitmeyer
Paul A. Meyers
Show All
Source
Cite
Save
Citations (3)
Mutant conformation of p53 translated in vitro or in vivo requires functional HSP90
1996
Proceedings of the National Academy of Sciences of the United States of America
Mikhail V. Blagosklonny
J Toretsky
S Bohen
Leonard M. Neckers
Show All
Source
Cite
Save
Citations (282)
EPISOME GENERATED C-MYC ANTISENSE RNA INHIBITS GROWTH AND TUMORIGENICITY OF A HUMAN NEUROENDOCRINE TUMOR-CELL LINE
1995
International Journal of Oncology
Angelo Rosolen
E. Frascella
J Toretsky
Lm Neckers
Show All
Source
Cite
Save
Citations (1)
Geldanamycin selectively destabilizes and conformationally alters mutated p53.
1995
Oncogene
Mikhail V. Blagosklonny
J Toretsky
Leonard M. Neckers
Show All
Source
Cite
Save
Citations (183)
1